NOVARTIS REPORTS 31% PROFIT RISE

The drug maker Novartis said Monday that first-quarter profit rose 31 percent from the year-earlier period, helped by demand for the hypertension treatment Diovan and a gain from the sale of its nutrition unit.

International Herald Tribune (http://www.iht.com/articles/2006/04/24/bloomberg/bxdrug.php)